Log in to save to my catalogue

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor progno...

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor progno...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1292380025

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis

About this item

Full title

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis

Publisher

United States: Public Library of Science

Journal title

PloS one, 2011-03, Vol.6 (3), p.e17745-e17745

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Colorectal cancer (CRC) remains one of the major cancer types and cancer related death worldwide. Sensitive, non-invasive biomarkers that can facilitate disease detection, staging and prediction of therapeutic outcome are highly desirable to improve survival rate and help to determine optimized treatment for CRC. The small non-coding RNAs, microRNA...

Alternative Titles

Full title

Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_plos_journals_1292380025

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_plos_journals_1292380025

Other Identifiers

ISSN

1932-6203

E-ISSN

1932-6203

DOI

10.1371/journal.pone.0017745

How to access this item